Paving the Path to Prevention: Managing Early Treatments for T1D Progression : Episode 7

Patient Selection For Teplizumab and Infusion Process

January 20, 2025

By Javier Morales, MD, FACP, FACE
Shira Eytan, MD, FACE

Opinion

Video

Panelists discuss how patient selection for teplizumab therapy requires screening for specific autoantibodies and stages of Type 1 diabetes, followed by a standardized 14-day outpatient infusion protocol with careful monitoring for side effects.

EP: 1.Living with Type 1 Diabetes

EP: 2.Screening Guidelines for Type 1 Diabetes

EP: 3.Stages and Symptoms of Type 1 Diabetes

EP: 4.Impact of Delayed Intervention in Stage 2 Type 1 Diabetes

EP: 5.Types of Antibody Screening Tests for Type 1 Diabetes

EP: 6.Overview of Teplizumab for Delaying Onset and Progression of Type 1 Diabetes

Now Viewing

EP: 7.Patient Selection For Teplizumab and Infusion Process

EP: 8.Final Thoughts on Identifying and Managing Patients with T1D

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!